APRILBIO is a South Korea-based biotechnology company focused on the research and development of protein and antibody therapeutics. Its pipeline includes long-acting biologic candidates using proprietary platform technologies.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!